Rheumatology Drug Updates: Ixekizumab Improves Work Productivity, plus Vobarilizumab Completes Phase 2 Trial in Rheumatoid Arthritis Michele B. Kaufman, PharmD, BCGP | Issue: September 2016 | September 9, 2016 Page: 1 2 3 | Single Page Share: